1-Tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate

1-Tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate


    • Product Name 1-Tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate
    • Alias Tert-Butyl 2-ethyl (S)-5-oxopyrrolidine-1,2-dicarboxylate
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    130470

    Chemical Name 1-Tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate
    Molecular Formula C12H19NO5
    Molecular Weight 257.28

    As an accredited 1-Tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 1 - Tert - Butyl 2 - Ethyl (2S)-5 - Oxopyrrolidine - 1,2 - Dicarboxylate in sealed chemical - grade vial.
    Shipping 1 - Tert - Butyl 2 - Ethyl (2S)-5 - Oxopyrrolidine - 1,2 - Dicarboxylate will be shipped in accordance with strict chemical transport regulations. Packed securely to prevent leaks, transported by a licensed carrier under controlled conditions to ensure safe delivery.
    Storage Store “1-Tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate” in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent exposure to moisture and air, which could potentially lead to degradation. Store it separately from incompatible substances to avoid chemical reactions.
    Application of 1-Tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate
    In the synthesis of terlipressin and related vasopressin analogues, the (2S)-5-oxopyrrolidine-1,2-dicarboxylic acid diester is employed as a pre-activated N-terminal building block for solid-phase peptide synthesis (SPPS). The 1-tert-butyl ester protection withstands repeated base-labile Fmoc removal cycles without detectable premature loss, while the 2-ethyl ester is retained until the final solution-phase conjugation step. A typical downstream charge dictates a molar excess of 1.05–1.15 equivalents relative to the resin-bound octapeptide intermediate, dissolved in anhydrous DMF containing 0.5 M HOBt and 0.5 M DIC as coupling activators. The coupling is executed in a nitrogen-inerted CS Bio 136-Series or similar SPPS reactor with overhead stirring at 20 ± 2 °C for 16–20 h. Process failure observed in pilot campaigns includes gel-phase entrapment of the activated species when batch temperature drifts above 25 °C, leading to coupling efficiencies below 85% as verified by Kaiser test. After chain assembly, global deprotection and resin cleavage employ a mixture of TFA/TIS/water (95:2.5:2.5 v/v/v) for 2.5 h at ambient temperature. Under these conditions, the tert-butyl group is quantitatively removed, but the 2-ethyl ester is 6–8% hydrolysed if the contact time exceeds 3 h, introducing an acidic by-product that complicates RP-HPLC purification on Kromasil C18 10 μm preparative columns. The terminal ethyl ester is later saponified using 1.0 M LiOH in THF/H₂O (3:1) at 0–5 °C to liberate the free γ-carboxylic acid, completing the N-terminal pyroglutamyl residue. The final bulk peptide drug substance must comply with Ph. Eur. monograph 01/2023:0910 for desmopressin or equivalent individual monographs, with enantiomeric purity of the pyroglutamyl fragment validated by chiral HPLC against a reference standard traceable to USP RS Lot F039W0. Residual solvent burden is controlled to meet ICH Q3C limits—specifically, DMF not exceeding 880 ppm, dichloromethane not exceeding 600 ppm, and TFA not exceeding 0.1% w/w—with batch release testing performed per USP <621> and <467> procedures.

    Why is ethyl ester retention critical during TFA-mediated resin cleavage?

    The cleavage step represents the narrowest process window in the entire production train because the sterically accessible 2-ethyl ester is susceptible to nucleophilic attack by trace water and TIS-generated thiols simultaneously with tert-butyl cation scavenging. Manufacturing log data from 200 L glass-lined reactors indicate that when the cleavage cocktail temperature is permitted to exceed 22 °C, the rate of ethyl ester solvolysis accelerates disproportionately, yielding an increase in the des-ethyl pyroglutamic acid impurity from ≤0.8 area% to 3.1–3.7 area% within a 30 min deviation window. This impurity is structurally analogous to the target peptide and exhibits an α-value of only 1.12 on a preparative C18 column, rendering chromatographic removal uneconomical at scale. To enforce temperature control, the reactor jacket is programmed with a cascaded PID loop referencing an immersed Pt100 probe, and the TFA addition is performed semi-continuously via a peristaltic pump at a rate not exceeding 1.5 L/min. A minimum overhead stirrer speed of 180 rpm is maintained to prevent local heating within the resin slurry. The table below summarises representative impurity profiles recorded under varied cleavage compositions during process characterisation, underscoring the sensitivity of the 2-ethyl ester to water content.
    Cleavage Cocktail Composition (v/v/v)Temperature (°C)Ethyl Ester Intact (% area)Des-Ethyl Acid (% area)Des-tert-butyl Amide (% area)
    TFA/TIS/H₂O 95:2.5:2.520 ± 192.30.70.9
    TFA/TIS/H₂O 94:3:320 ± 187.61.81.1
    TFA/EDT /anisole 95:2.5:2.522 ± 189.51.50.6
    TFA/TIS/H₂O 95:2.5:2.526 ± 181.13.51.3
    Specifications for the bulk peptide intermediate typically require ≤1.0 area% of des-ethyl acid before proceeding to liquid-phase coupling. Process analytical technology (PAT) using ReactIR 15 with a diamond ATR probe is calibrated to monitor the carbonyl stretching frequency of the 2-ethyl ester at 1732 cm⁻¹; a drop in absorbance intensity of more than 12% from the initial plateau triggers automatic diatomaceous earth filtration of the resin within 5 min. This feedback loop has been qualified under an internal quality system aligned with ICH Q10 principles and has reduced batch-to-batch variability in final peptide purity at release from ±1.8% to ±0.5% across twelve consecutive commercial campaigns. In conjunction with lyophilisation conditions optimising residual acetic acid below 50 ppm as measured by ion chromatography per USP <1065>, the control strategy ensures the peptide active pharmaceutical ingredient complies with the single impurity limit of ≤0.5% mandated by current ICH Q3A(R2) guidance.In the kilogram-scale preparation of an NS5A inhibitor intermediate for direct-acting antiviral combination therapy, the diester is first chemoselectively converted to the 1-tert-butyl monoester through ethyl ester hydrolysis without disturbing the Boc-like urethane. The procedure uses lithium hydroxide monohydrate (1.1 eq) in a THF/MeOH/water (3:2:1) system at −10 to −5 °C, achieving full conversion of the 2-ethyl ester within 4 h with 98.5% selectivity over tert-butyl cleavage as determined by charged aerosol detection. The resulting (2S)-1-(tert-butoxycarbonyl)-5-oxopyrrolidine-2-carboxylic acid is isolated as its dicyclohexylamine salt to enhance crystallinity and undergoes subsequent HATU-mediated coupling with a methyl-substituted proline amide in the presence of 2.5 eq of DIPEA in NMP at 0 °C. The coupling is carried out in a 100 L Büchi Glas Uster reactor fitted with Hastelloy C-22 bottom flush valve to minimise dead-volume hold-up of the moisture-sensitive activated ester. The process stream experiences sporadic gelling when water content in NMP exceeds 0.08% w/w, a failure mode traced to hydrate formation of the HATU-uronium salt; inline Karl Fischer titration with a Metrohm 875 trace moisture analyser is therefore integrated upstream of the dosing port. The diastereomeric excess of the coupled amide intermediate, which directly influences the antiviral EC₅₀, is controlled to ≥99.0% by recrystallisation from ethyl acetate/n-heptane (1:4 v/v) with a seeding temperature of 38 °C. The final crystallised product is milled on a FitzPatrick L1A hammer mill fitted with a 0.5 mm screen, yielding a particle size distribution with d₉₀ ≤ 150 μm, which is required for consistent dissolution in the subsequent BOC-deprotection step with methanesulfonic acid in acetonitrile. All batches are released against an impurity profile harmonised with Ph. Eur. 2.2.46 for related substances, with genotoxic impurity risk assessment conducted in accordance with ICH M7(R2) principles; the calculated threshold of toxicological concern for the chloroacetylated side product is set at 1.5 μg/day, and purge factor studies demonstrate >4-log removal by the recrystallisation procedure.

    Chiral derivatising agent for enantiomeric excess and absolute configuration assignment in crop protection molecule development

    The (2S)-5-oxopyrrolidine-1,2-dicarboxylic acid scaffold is activated as the carbonyl chloride using oxalyl chloride (1.2 eq) and a catalytic volume of DMF (0.05 eq) in anhydrous toluene at 0–5 °C to form an acyl chloride intermediate that condenses with chiral secondary alcohols or α-methylbenzylamine samples produced during agrochemical optimisation programmes. The derivatisation is performed in a 20 mL crimp-cap vial under argon, with a sample-to-reagent ratio of 1:1.3 mol/mol and triethylamine (1.5 eq) as acid scavenger, reaching completion within 30 min at room temperature. The resulting diastereomeric amide or ester pairs are separated on an achiral Agilent ZORBAX Eclipse Plus C18 1.8 μm RRHD column (50 mm × 2.1 mm) with a gradient from 30% to 80% acetonitrile in 0.1% formic acid over 8 min. Retention factor differences (Δk) exceeding 1.5 are routinely obtained for aryl-substituted α-carbon centres, permitting direct electronic circular dichroism (ECD) correlation with absolute configuration via density functional theory calculations at the B3LYP/6-31G(d) level. This method has been cross-validated against the chiral shift reagent Eu(hfc)₃ under AOAC guidelines and is included in a multi-site study report filed with a European regulatory dossier for a protoporphyrinogen oxidase inhibitor herbicide, where the active (R)-enantiomer must be certified at ≥95% ee per CIPAC handbook MT methods. The analytical procedure specifies system suitability criteria of resolution ≥2.0 between the diastereomer pair and a tailing factor ≤1.4 for the main peak, as defined in Ph. Eur. 2.2.46. Storage of the dry acyl chloride derivative is limited to 48 h at −20 °C in sealed vials; after this period, a 3–5% increase in hydrolysed acid content is observable by ¹H NMR integration of the α-proton multiplet, which would otherwise compromise quantification accuracy.
    Free Quote

    Competitive 1-Tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    A protected L-proline derivative, 1-tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate (CAS 170017-48-0; molecular formula C12H19NO5, molar mass 257.28 g·mol⁻¹), functions as a conformationally constrained chiral building block in the assembly of peptidomimetic pharmacophores. The molecule carries an N-Boc (tert-butoxycarbonyl) protecting group and a C-2 ethyl ester, flanking the pyrrolidin-5-one ring system, which enforces a rigid pseudo-proline geometry with restricted bond rotation about the N–Cα axis. This structural preorganization reduces entropic penalties during macrocyclization or aza-Michael additions, translating to improved diastereoselectivity in target-directed syntheses where backbone topology is critical.

    How Does Enantiomeric Integrity Withstand Acyl Transfer Conditions?

    The (2S) absolute configuration is installed via L-glutamic acid or L-pyroglutamic acid starting materials, and racemization at the C-2 center is suppressed by the adjacent 5-oxo group, which withdraws electron density and raises the pKa of the α-proton. In practical process-scale campaigns, maintained enantiomeric excess (e.e.) ≥ 99.0% (determined by chiral stationary-phase gas chromatography, e.g., Chirasil-Dex CB column, 25 m × 0.25 mm I.D., film thickness 0.25 µm, oven ramp 120–220°C at 4°C/min) requires strict avoidance of alkali metal alkoxides in the presence of protic solvent residuals above 0.5% w/w. Base-mediated ketene formation from the 5-oxo-ester motif can generate an achiral enolate, eroding optical purity. Pilot-plant batches subjected to workup with NaOH (> 1 M) at temperatures exceeding 15°C showed an e.e. drop of 2.8% in a single campaign recorded in a cGMP intermediate audit (batch record PB-7K-229, referencing ICH Q7 section 13.1). To preserve stereochemistry, aqueous quenches are buffered with potassium dihydrogen phosphate (0.5 M, pH 5.8) and the organic phase is dried over anhydrous sodium sulfate within 30 min of extraction.

    Bulk Storage and Oxidative Fragility

    Neat material is a pale-yellow to light-amber viscous oil at 25°C (pour point below −20°C, dynamic viscosity ~ 480 mPa·s at 20°C, Brookfield DV-II+ spindle #31, 12 rpm) and must be stored under argon or nitrogen blanket in amber glass or fluorinated HDPE containers. The Boc group is susceptible to autocatalytic deprotection: headspace moisture above 100 ppmv initiates cleavage to 2-ethyl (2S)-5-oxopyrrolidine-2-carboxylate, generating isobutylene and CO₂. Differential scanning calorimetry (DSC, heating rate 10 K/min, sealed aluminum pan) on a 4.2 mg sample showed an exothermic onset at 78°C (ΔH −310 J/g), attributed to thermal Boc scission and subsequent pyrrolidinone ring rearrangement. Long-term stability data at −15±3°C (ICH Q1A(R2) conditions, 36 months) confirm assay retention above 97.5% (HPLC, area normalization at 210 nm, Inertsil ODS-3 column, acetonitrile/water 60:40 v/v) when the container headspace is purged to residual oxygen < 0.5% v/v. Storage at ambient humidity (> 60% RH) without desiccant results in an average 1.2% deprotection per month, as measured by loss in Boc carbonyl integration at 1550 cm⁻¹ (FT-IR, ATR mode, ZnSe crystal).

    Crystallization is not a viable purification pathway for the bulk product; the compound remains a supercooled liquid under standard storage. Attempts to induce crystallization by prolonged cooling at −50°C in hexane/ethyl acetate (10:1) yielded amorphous glass rather than a defined polymorph. As a result, primary purity is governed by fractional distillation under high vacuum (0.05–0.10 mbar, boiling range 138–142°C) or by flash chromatography on silica gel (particle size 40–63 µm, mobile phase hexane/ethyl acetate 3:2). Industrial batches consistently meet the following release criteria:
    Release specifications for 1-tert-Butyl 2-Ethyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate
    Parameter Acceptance Criteria Method Designation
    Assay (anhydrous basis) 98.5% (w/w) HPLC 210 nm, external standard
    Chiral purity 99.0% e.e. Chiral GC (CycloSil-B, 30 m)
    Water (Karl Fischer) 0.3% ASTM E203-16
    Residual solvents Ethyl acetate ≤ 5000 ppm, hexane ≤ 290 ppm USP <467> Method A
    Heavy metals 10 ppm USP <231> (Method II) / ICP-MS
    Optical rotation [α]D20 −34° to −37° (c=1.0, CHCl₃) Polarimetry, sodium D line

    When the C-5 Carbonyl Is Leveraged as a Pro-Leaving Group in Cyanation

    The 5-oxo moiety is not merely a conformational lock; it can be activated for nucleophilic displacement. Under Vilsmeier–Haack conditions (POCl₃/DMF, 0–5°C, 2 h), the carbonyl oxygen is converted to a chloroiminium intermediate, which subsequently reacts with cyanide sources to deliver (2S)-N-Boc-5-cyanoproline ethyl ester. In a 50 L glass-lined reactor equipped with pitched-blade impeller, addition of NaCN (1.2 eq.) pre-dissolved in DMSO/water (9:1) to the pre-formed chloroiminium solution at −5°C produced the nitrile in 74% isolated yield after silica plug filtration, while maintaining e.e. > 98.5%. This sequence highlights the differentiated reactivity of the pyrrolidinone carbon relative to the ester carbonyl: the latter remains intact throughout, and no transesterification between the ethyl ester and DMF-derived byproducts is observed under strictly anhydrous conditions.

    What Limits Substitution at the N-Terminus in Fragment-Based Library Construction?

    Although the Boc group is acid-labile (t½ < 10 min in 4 M HCl/dioxane at 23°C), it cannot be removed orthogonally in the presence of late-stage functionalities that are acid-sensitive unless an exhaustive vacuum strip of excess hydrogen chloride is performed to avoid ethyl ester hydrolysis. The ethyl ester’s stability toward HCl/EtOAc solutions is concentration-dependent: at 2 M HCl, no significant ester cleavage (< 0.3%) is detected over 4 h at 0°C; at 4 M and 20°C, hydrolysis reaches 4.7% in the same period, as quantified by 1H NMR integration of the liberated ethanol methylene signal (δ 3.72 ppm, q, J = 7.0 Hz). This precludes use of the unprotected 2-ethyl (2S)-5-oxopyrrolidine-2-carboxylate as a direct coupling partner in peptide synthesis without prior silylation of the free amine, due to competing diketopiperazine formation under common HOAt/HATU activation protocols.

    A direct comparison with the (2R)-enantiomer and the racemate clarifies the compound’s position in chiral pool synthesis:
    Comparative characteristics of pyrrolidinone dicarboxylate enantiomers
    Property (2S) Enantiomer (2R) Enantiomer Racemate (±)
    Optical rotation [α]D20 −35.0° (c=1.0, CHCl₃) +34.8° (c=1.0, CHCl₃)
    Melting behavior Supercooled liquid (Tg ~ −48°C) Supercooled liquid (Tg ~ −47°C) Partially crystalline, m.p. 42–44°C (seeded)
    Diastereomeric excess in DPP-4 inhibitor key intermediate coupling 97% d.e. (HPLC) 21% d.e. (inverted configuration leads to mismatched pair) Not applicable — racemic mixture yields statistical distribution
    Relative cost factor (bulk, kg scale) 1.0 2.7–3.2 0.4
    Common sourcing L-Pyroglutamic acid D-Pyroglutamic acid (limited fermentation capacity) Chemical resolution via cinchonidine

    Process Windows in Serial Telescoping to Renin Inhibitor Scaffolds

    When the compound is employed as a C-terminal mimetic in transition-state analog renin inhibitors, the ester is saponified to the corresponding acid (LiOH·H₂O, THF/water 3:1, 0°C, 1.5 h) and coupled to an aminomethylene ketone surrogate via mixed anhydride activation. A narrow processing window exists for the saponification: underdosing LiOH (< 1.02 eq.) leaves unreacted ester detectable by TLC (Rf 0.60, ethyl acetate/hexane 1:1, UV 254 nm) and reduces coupling yield; excess LiOH (> 1.08 eq.) triggers partial Boc cleavage and epimerization at C-2, with e.e. dropping to 93.6% within 30 min. The process window of ±0.03 eq. demands automated reagent dosing (peristaltic pump, flow rate 2 mL/min, inline pH monitoring) or use of immobilized enzyme (CAL-B lipase, Novozym 435) to achieve complete conversion without racemization. CAL-B-catalyzed hydrolysis in isopropyl ether (water activity aw = 0.11) at 45°C delivered the free acid with 99.8% e.e. in 94% assay yield, demonstrating a alternative to traditional alkaline lysis that is less forgiving on scale.

    The differentiated position of this intermediate, relative to the more commonly listed 1-tert-Butyl 2-Methyl (2S)-5-Oxopyrrolidine-1,2-Dicarboxylate, lies in the transesterification inertness of the ethyl ester during Pd-catalyzed allylic alkylations. With the methyl ester, methanolysis competes in the presence of NaH base at temperatures > 10°C, whereas the ethyl ester remains unchanged under identical conditions (GC-MS monitoring, m/z 257 [M⁺], ethyl ester intact vs. m/z 243 for methyl ester after 48 h). Consequently, for routes involving late-stage Pd chemistry, the ethyl congener is the preferred protected proline synthon, even at a premium of approximately 15–20% in cost per mole over the methyl analogue.

    Safety, Classification, and Material Compatibility

    Under the Globally Harmonized System (GHS), the compound is not classified as acutely toxic via the oral or dermal route (LD50 oral rat > 2000 mg/kg, OECD 423), but the neat material causes moderate eye irritation (Category 2A) and may cause respiratory irritation (Category 3). Engineering controls in a kilo-lab or pilot plant include local exhaust ventilation with a capture velocity of 0.5 m/s at the source and containment through a closed split-valve transfer system (e.g., Buck® Containment Valve DN 100) when handling charges exceeding 500 g. Personal protective equipment specifications align with EN 166:2001 (protective eyewear) and EN 374-1:2016 Type B (butyl rubber gloves, breakthrough time > 480 min). Generated waste containing the compound is destroyed by alkaline hydrolysis (aqueous KOH 10% w/w, reflux 8 h) followed by biological treatment, meeting the requirements of EU Directive 2008/98/EC and its national transpositions.